ReShape Lifesciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
38.75
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-17.75
|
-26.00
|
-8.25
|
-46.48%
|
|
2022-06-30
|
-18.00
|
-25.00
|
-7.00
|
-38.89%
|
|
2022-03-31
|
-17.25
|
-22.00
|
-4.75
|
-27.54%
|
|
2021-12-31
|
-8.75
|
-27.00
|
-18.25
|
-208.57%
|
|
2021-09-30
|
-7.50
|
-74.00
|
-66.50
|
-886.67%
|
|
2021-06-30
|
-0.22
|
-23.50
|
-23.28
|
-10581.82%
|
|
2021-03-31
|
-0.53
|
-66.00
|
-65.47
|
-12352.83%
|
|
2020-12-31
|
-0.44
|
-1.23
|
-0.79
|
-179.55%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-73.00
|
|
2021-12-31
|
-190.50
|
|
2020-12-31
|
-5.49
|
|
2019-12-31
|
-14.85
|
|
2018-12-31
|
-113413.10
|
|
2017-12-31
|
-12.43
|
|
2016-12-31
|
-759.31
|
|
2015-12-31
|
-318.50
|
|
2014-12-31
|
-2000095.70
|
|
2013-12-31
|
-4000000.00
|
|
2012-12-31
|
-4000000.00
|
|
2011-12-31
|
-4000000.00
|
|
2010-12-31
|
-4000000.00
|
|
2009-12-31
|
-4000000.00
|
|
2008-12-31
|
-4000000.00
|
|
2007-12-31
|
-2000000.00
|